Obesity.
Finer
Nicholas
N
Wellcome Trust Clinical Research Facility, Addenbrooke's Hospital, Cambridge. nf237@cam.ac.uk
D000293:Adolescent; D000328:Adult; D000368:Aged; D019440:Anti-Obesity Agents / Q000627:therapeutic use; D001067:Appetite Depressants / Q000627:therapeutic use; D015992:Body Mass Index; D002648:Child; D002675:Child, Preschool; D003503:Cyclobutanes / Q000627:therapeutic use; D004038:Diet, Reducing; D004739:England / Q000453:epidemiology; D015444:Exercise; D005260:Female; D020022:Genetic Predisposition to Disease; D006801:Humans; D007783:Lactones / Q000627:therapeutic use; D020738:Leptin / Q000502:physiology; D008019:Life Style; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000150:complications / Q000453:epidemiology / Q000235:genetics / Q000628:therapy; D009767:Obesity, Morbid / Q000601:surgery / Q000628:therapy; D000077403:Orlistat; D015995:Prevalence; D012307:Risk Factors; D014852:Wales / Q000453:epidemiology
D019440:Anti-Obesity Agents; D001067:Appetite Depressants; D003503:Cyclobutanes; D007783:Lactones; D020738:Leptin; D000077403:Orlistat; C058254:sibutramine